Literature DB >> 24318899

Cell internalization SELEX: in vitro selection for molecules that internalize into cells.

Amy Yan1, Matthew Levy.   

Abstract

Aptamer technology allows for the selection of nucleic acids that can bind to and enter cells. By establishing conditions during the selection that eliminate cell-surface binders as well as non-internalizing RNAs, only extremely tightly bound aptamers or aptamers that have internalized are recovered. We describe a general scheme for selecting RNA molecules that are capable of internalizing into cells and discuss the factors that can affect a successful selection. Much like standard cell-surface selections, these types of selections should be possible independent of detailed knowledge of the cell surface.

Mesh:

Substances:

Year:  2014        PMID: 24318899     DOI: 10.1007/978-1-62703-730-3_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

Review 1.  Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?

Authors:  S K Haßel; G Mayer
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

2.  Aptamers as Reversible Sorting Ligands for Preparation of Cells in Their Native State.

Authors:  Bethany Powell Gray; Martin D Requena; Michael D Nichols; Bruce A Sullenger
Journal:  Cell Chem Biol       Date:  2019-12-23       Impact factor: 8.116

Review 3.  The delivery of therapeutic oligonucleotides.

Authors:  Rudolph L Juliano
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

4.  Tunable cytotoxic aptamer-drug conjugates for the treatment of prostate cancer.

Authors:  Bethany Powell Gray; Linsley Kelly; Douglas P Ahrens; Ashley P Barry; Christina Kratschmer; Matthew Levy; Bruce A Sullenger
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-16       Impact factor: 11.205

Review 5.  Aptamers and their applications in nanomedicine.

Authors:  Hongguang Sun; Youli Zu
Journal:  Small       Date:  2015-02-11       Impact factor: 13.281

6.  Optimization of RNA Aptamer SELEX Methods: Improved Aptamer Transcript 3'-End Homogeneity, PAGE Purification Yield, and Target-Bound Aptamer RNA Recovery.

Authors:  Chandan Narayan; Suresh Veeramani; William H Thiel
Journal:  Nucleic Acid Ther       Date:  2021-11-10       Impact factor: 5.486

7.  Development of Novel Aptamer-Based Targeted Chemotherapy for Bladder Cancer.

Authors:  Yao Wang; Yang Zhang; Peng-Chao Li; Jiajie Guo; Fan Huo; Jintao Yang; Ru Jia; Juan Wang; Qiju Huang; Dan Theodorescu; Hanyang Yu; Chao Yan
Journal:  Cancer Res       Date:  2022-03-15       Impact factor: 13.312

Review 8.  From selection hits to clinical leads: progress in aptamer discovery.

Authors:  Keith E Maier; Matthew Levy
Journal:  Mol Ther Methods Clin Dev       Date:  2016-04-06       Impact factor: 6.698

9.  New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization.

Authors:  Abdullah Ozer; John M Pagano; John T Lis
Journal:  Mol Ther Nucleic Acids       Date:  2014-08-05       Impact factor: 10.183

10.  Oligonucleotide aptamers: new tools for targeted cancer therapy.

Authors:  Hongguang Sun; Xun Zhu; Patrick Y Lu; Roberto R Rosato; Wen Tan; Youli Zu
Journal:  Mol Ther Nucleic Acids       Date:  2014-08-05       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.